1365-2567/asset/olbannerleft.gif?v=1&s=acb355fd099dcd1bbcec1ce20c043b048e8c9192)
1365-2567/asset/olbannerright.gif?v=1&s=1b43856278787642cdd0f2578d09705a2a0a8edf)
ORIGINAL ARTICLE
You have full text access to this OnlineOpen article
Identification of a unique double-negative regulatory T-cell population
Article first published online: 4 NOV 2011
DOI: 10.1111/j.1365-2567.2011.03502.x
© 2011 The Authors. Immunology © 2011 Blackwell Publishing Ltd
Additional Information
How to Cite
Lee, B. O., Jones, J. E., Peters, C. J., Whitacre, D., Frelin, L., Hughes, J., Kim, W.-K. and Milich, D. R. (2011), Identification of a unique double-negative regulatory T-cell population. Immunology, 134: 434–447. doi: 10.1111/j.1365-2567.2011.03502.x
Publication History
- Issue published online: 4 NOV 2011
- Article first published online: 4 NOV 2011
- Accepted manuscript online: 2 SEP 2011 03:49AM EST
- Received 4 May 2011; revised 5 August 2011; accepted 23 August 2011.
References
- 1. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2:389–400.
- 2. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531–62.
- 3, . Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3:223–32.
- 4, . Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10:801–5.
- 5, , , . Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002; 3:756–63.
- 6, . Infectious immunological tolerance. Immunology 1971; 21:903–14.
- 7, , , , . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151–64.
- 8, , , . CD4+ CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245–53.
- 9, , , , . Stimulation of CD25+ CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3:135–42.
- 10, , , , , , . CD4+ CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16:311–23.
- 11, , et al. Expression of the integrin αEβ7 identifies unique subsets of CD25+ as well as CD25– regulatory T cells. Proc Natl Acad Sci U S A 2002; 99:13031–6.
- 12, , . Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295–302.
- 13, , et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004; 34:623–30.
- 14, , , , , , , . Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303–10.
- 15, , , . Developmental regulation of Foxp3 expression during ontogeny. J Exp Med 2005; 202:901–6.
- 16, , , , , . Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329–41.
- 17, , . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057–61.
- 18, , et al. Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells. Int Immunol 2004; 16:1643–56.
- 19, , , , . Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000; 6:782–9.
- 20, , , , , . Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J Immunol 2005; 175:3409–16.
- 21, , et al. Isolation and characterization of human antigen-specific TCR αβ+ CD4– CD8– double-negative regulatory T cells. Blood 2005; 105:2828–35.
- 22, , et al. Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 2005; 174:4535–44.
- 23, , , , . Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003; 170:1846–53.
- 24, , , , , . Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation. Xenotransplantation 2008; 15:56–63.
- 25, , et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway. J Immunol 2006; 177:6920–9.
- 26, , , , . Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression. Int Immunopharmacol 2011; 11:597–603.
- 27, , et al. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur J Immunol 2011 EPub ahead of print.
- 28, , et al. Adoptive transfer of DNT cells induces long-term cardiac allograft survival and augments recipient CD4+ Foxp3+ Treg cell accumulation. Transpl Immunol ????; 24:119–26.
- 29, , , , , . Nondeletional T-cell receptor transgenic mice: model for the CD4+ T-cell repertoire in chronic hepatitis B virus infection. J Virol 2000; 74:7587–99.
- 30, , , , , , , . Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005; 79:3016–27.
- 31, , , , , , , . A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A 2004; 101:14913–8.
- 32, , , , . Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J Virol 1994; 68:5469–75.
- 33, , , , , . The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J Virol 1996; 70:7056–61.
- 34, , , , , . Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem 1993; 268:1332–7.
- 35, , , , . Rapid “tea-bag” peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett 1991; 30:59–68.
- 36, , . TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 2001; 167:6188–94.
- 37, , , , , . Distinct roles of CTLA-4 and TGF-β in CD4+ CD25+ regulatory T cell function. Eur J Immunol 2004; 34:2996–3005.
- 38, , , , , , , . Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo. J Immunol 2006; 177:4376–83.
- 39, , , , , , . Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol 2002; 32:2888–96.
- 40, , , , , . Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A 1997; 94:14648–53.
- 41, , et al. Interaction of the hepatitis B core antigen and the innate immune system. J Immunol 2009; 182:6670–81.
- 42, , , , , , . IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 2001; 98:8732–7.
- 43, , , , , . Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195:1523–32.
- 44, . Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells. Microbiol Immunol 2003; 47:453–60.
- 45, , , , , , . Modulation of the CD8+ T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005; 79:3322–8.
- 46, , , , , , . Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41:771–8.
- 47, , et al. Antigen-induced regulatory T cells in HBV chronically infected patients. Virology 2007; 368:41–9.
- 48, , , , , , . CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9:1144–50.
- 49, , et al. Only the CD62L+ subpopulation of CD4+ CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005; 105:2220–6.
- 50, , , , . Donor-type CD4+ CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196:389–99.
- 51, , . CD4+ CD25+ regulatory T cells in hematopoietic stem cell transplantation. Curr Top Microbiol Immunol 2005; 293:265–85.
- 52, , , . Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol 2005; 175:4180–3.
- 53, , , , , . CD4+ CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006; 176:1582–7.
- 54, , , , . Human CD4+ CD25+ regulatory T cells suppress NKT cell functions. Cancer Res 2003; 63:4516–20.
- 55, , , , . Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004; 172:4676–80.
- 56, , , , , , , . Modulation of monocyte/macrophage function by human CD4+ CD25+ regulatory T cells. Hum Immunol 2005; 66:222–30.
- 57. Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 2003; 75:8S–12S.
- 58, , , , , , . A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737–42.
- 59, , , , . Cutting edge: contact-mediated suppression by CD4+ CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol 2005; 174:1783–6.
- 60, , , , , . T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006; 177:6780–6.
- 61, , et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257–65.
- 62, , et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110:1225–32.